Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Merck KGaA

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Merck KGaA's 2013 sales performance.

Merck KGaA

Sanofi’s PD-1 inhibitor starts EU review for skin cancer

Sanofi’s PD-1 inhibitor starts EU review for skin cancer intended - to help it break into one of the most hotly-contested pharma markets, currently led by Bristol-Myers Squibb and Merck &Co/MSD. ... In addition to chasing companies in the category with already-marketed drugs - which also include Roche,

Merck KGaA inks deal for Medisafe adherence app

Merck KGaA inks deal for Medisafe adherence app Merck KGaA has signed a wide-ranging deal with US-Israeli company Medisafe to develop customised versions of its treatment adherence mobile app for use alongside Merck’s cardiometabolic drug products. ... It is estimated that approximately 50% of

GSK joins Reckitt in passing on Pfizer’s consumer health unit

GSK joins Reckitt in passing on Pfizer’s consumer health unit Pfizer isn’t the first to have trouble finding a buyer; last month Nestle opted not to press ahead with a 4bn purchase of Merck KGaA’s consumer health unit, with

Lundbeck signs $1.1bn deal for Prexton and Parkinson’s drug

Lundbeck signs $1.1bn deal for Prexton and Parkinson’s drug Prexton was set up in 2012 as a spin-out from Merck Serono’s R&D operations following the closure of its Geneva R&D centre.

BMS gets OK for monthly Opdivo dosing

BMS gets OK for monthly Opdivo dosing cancer. It is competing in the marketplace with two other PD-1 inhibitors - Merck &Co/MSD’s Keytruda (pembrolizumab) and Roche’s Tecentriq (atezolizumab) - as well as PD-L1 inhibitors Imfinzi ... durvalumab) from AstraZeneca and Merck KGaA/Pfizer’s

[ Previous 5 results ] 5 6 7 8 9 10 11 12 13 14 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Attigo (part of the Mednet Group)

Inclusion drives innovation. Attigo, a social enterprise, helps pharma and the socially conscious business shape the future by engaging with...

Latest intelligence

Mike Elliott Gilead
Keeping up the fight against HIV and using the lessons to tackle other threats
Danny Buckland interviews Gilead’s Mike Elliott...
Digital therapeutics and their impact on society
Head of Customer Experience Elisa del Galdo explores how healthcare technology can help chronic disease patients and asks what makes a good digital therapeutic?...
Healthanuary?
Whether you are taking part in Dry January, Veganuary, or any other health regime, just keep going!...

Infographics